“EXCESS MORTALITY IN PATIENTS WITH ASTHMA ON LONG-ACTING β2-AGONISTS” J. HASFORD AND J.C. VIRCHOW. EUR RESPIR J 2006; 28: 900–902.
Unfortunately, a small section of text in the fifth paragraph of the above paper was reported incorrectly. It should have appeared as follows: “Studies similar in size to SMART are not available for formoterol, which has been approved in the USA in a 12-μg formulation based on two 12-week studies [15, 16] and a 1-yr study in children aged 5–12 yrs [4].” The authors apologise for this error.
- © ERS Journals Ltd